Functional outcomes, treatment satisfaction, decisional regret, and the impact of institutional factors after robotic vs. retropubic radical prostatectomy: a 5 year follow-up of the HAROW study

• Conditions: C61; Malignant neoplasm of prostate

• Registration Number: DRKS00011501
• Lead Sponsor: Klinik und Poliklinik für UrologieTU Dresden

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-01-10
• Study Completion: 2018-02-05
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: Male
• Target Recruitment: 936

Inclusion Criteria

1) Patients must have taken part in the HAROW study and have consented to long-term follow-up.
2) Patients must have undergone either retropubic or robotic-assisted radical prostatectomy.
3) Patient data must have been sufficient for analysis in the HAROW study.

Inclusion criteria from the HAROW study:

4) Newly diagnosed patients with a prostate cancer that is limited to the prostate gland (max. tumor staging T2c)
5) Patients without known metastases (N0, M0)

Exclusion Criteria

1) Recurrence of prostate cancer
2) Tumor staging T3 or greater

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary endpoint is to compare long-term functional outcome (EPIC-26).<br>

Secondary Outcome Measures

Name	Time	Method
Secondary endpoints are decisional regret (Decision regret scale), the retrospective judgment of the decision-making process (Degner scale) and quality of life (EORTC-QOL-30).